Navigation Links
Internal Fixation Systems, Inc. Announces Form S-1 Declared Effective by SEC and Anticipated Quotation for Trading on OTCQB

SOUTH MIAMI, Fla., May 18, 2011 /PRNewswire/ -- Internal Fixation Systems, Inc (IFS)announced today that its Registration Statement on Form S-1 (SEC File No.  333-170008) was declared effective by the Securities and Exchange Commission ("SEC") on May 15, 2011.  In addition and contemporaneous with the effectiveness of the  Registration Statement on Form S-1, IFS registered its common shares under the Securities Exchange Act of 1934 (the "1934 Act") and has voluntarily become subject to the reporting obligations under the 1934 Act.  IFS anticipates that, subject to FINRA approval, IFS' common shares will become quoted for trading on the OTCQB.

About Internal Fixation Systems:

IFS is a medical technology company specializing in the manufacture and marketing of generically priced orthopedic and podiatric surgical implants.  Our strategy is to offer high quality, cost effective surgical implants that are equivalent in quality, design, functionality and materials to the current industry "Gold Standards".  We focus on products that no longer have patent protection, products that are used every day in surgery.  This, along with our innovative modular design of surgery sets allows the company to have substantially lower R&D and FDA approval costs and also allows us to maintain substantially lower field inventory costs.

The company has FDA 510(k) approval for ten cannulated screw system products.  Applications have been submitted for additional products including locking small fragment plates and locking distal radius plate along with corresponding instrument sets.  We expect to receive FDA approval for these products in the second quarter of 2011 and that these products will be for sale by year-end.

IFS was started in 2006 and current customers include surgery center operators, hospitals and individual orthopedic surgeons.

The IFS management team is led by noted healthcare entrepreneur, Stephen Dresnick, MD, best known as the founder and CEO of Sterling Healthcare.  "We are very excited to have completed this important milestone," said Dr. Dresnick. "The IFS team has been hard at work laying the foundation for our future activities."

VP of Sales Ken West, who has over 20 years of sales experience in the Orthopedic and Spine implant  industry states, "Our commitment of producing high quality, low costs surgical implants is exactly what our clients have been requesting  for years."

This press release contains projections and forward-looking information that involve various risks and uncertainties regarding future events.  Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of Internal Fixation, such as the statements that (i) Internal Fixation anticipates that its shares will be quoted for trading on the OTCQB [or the OTCBB]; (ii).certain of Internal Fixation's products will become commercialized; and various other risks described from time to time in SEC reports filed by Internal Fixation.  There are numerous risks and uncertainties that could cause actual results and Internal Fixation's plans and objectives to differ materially from those expressed in the forward-looking information, including: (i)Internal Fixation's inability to become quoted on the OTCQB (or OTCBB) for any reason; (ii)Internal Fixation's inability to remain current in its reporting obligations with the SEC; and  (iii) Internal Fixation's inability to secure the financing necessary to continue its operations.  Actual results and future events could differ materially from those anticipated in such information.  These and all subsequent written and oral forward-looking information are based on estimates and views of  management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, IFS  does not intend to update these forward-looking statements.

For further information, please contact: Laura Cattabriga, Chief Financial Officer, 786 268 0995,

SOURCE Internal Fixation Systems, Inc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Board of Internal Medicine President Named to Alzheimers Study Group
2. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
3. Internal Fixation Systems to Sponsor and Exhibit at Wallstreet Spring Break Growth and Value Investor Conference in Fort Lauderdale, FL March 3-4, 2010
4. Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Companys First Synthetic Internal Use Sealant
5. Internal Consulting Organizations Need to Show Value to Organizational Leadership
6. Nutraceutical Leader Announces Internal Promotions of Key Personnel
7. Using Internal Communications to Help Build a Credible External Message Regarding New Pharmaceutical Products
8. Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine
9. International Medical News Group Relaunches Internal Medicine News Digital Network and Hospitalist News Digital Network
10. Corporate Affairs Role in Internal and External Relationships Key to Organizational Success
11. Toriseva Law and Karon & Dalimonte LLP: Archives of Internal Medicine Article Faults Manufacturers of IVC Filters
Post Your Comments:
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
Breaking Medicine News(10 mins):